Patient-derived NKG2D-CAR NK displayed superior cytotoxic activity against MM cells in vitro compared with memory NKG2D-CAR T-cells and mediated more efficient tumor control in a mouse model without any sign of adverse side effects [156]. The gene discussed is KLRK1; the disease is Miyoshi myopathy.